Late pulmonary toxicity after treatment for Hodgkin's disease

Anticancer Research

Volumn 17, Issue 6 D, 1997, Pages 4739-4742

  Villani, Fabrizio ^a   De Maria, Patrizia ^a   Bonfante, Valeria ^a   Viviani, Simonetta ^a   Laffranchi, Alberto ^a   Dell'Oca, Italo ^a   Dirusso, Anna ^a   Zanini, Marcello ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Hodgkin's disease; Pulmonary toxicity; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBON MONOXIDE; DACARBAZINE; DOXORUBICIN; VINBLASTINE;

ADOLESCENT; ADULT; ARTICLE; COUGHING; DYSPNEA; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HODGKIN DISEASE; HUMAN; LUNG DIFFUSION; LUNG FUNCTION TEST; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYMPTOM; TOTAL LUNG CAPACITY; VITAL CAPACITY;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARBON MONOXIDE; DACARBAZINE; DOXORUBICIN; FEMALE; FORCED EXPIRATORY FLOW RATES; FORCED EXPIRATORY VOLUME; HODGKIN DISEASE; HUMANS; LUNG; MALE; MEDIASTINUM; MIDDLE AGED; PULMONARY VENTILATION; RADIOTHERAPY; SPLEEN; VINBLASTINE; VITAL CAPACITY;

EID: 0031427017     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Santoro A, Bonadonna G, Valagussa P, Zucali R, Viviani S, Villani F, Pagnoni AM, Bonfante V, Musumeci R, Crippa F, Tesoro Tess JDF, Banfi A: Long term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. J Clin Oncol 5: 27-37, 1987.
2. Eghbali H, Bonichon F, David B, Rojouan J, Audebert AA, Blanc CM, Zittoun R, Hoerni B, Naiman A and Pierre and Marie Curie Group (GPMC): Combination of ABVD and radiotherapy in early stages of Hodgkin's disease: analysis of a series of 94 patients. Radiother Oncol 18: 127-136, 1990.
3. Brice P, Tredaniel J, Monsuer JJ, Marolleau JP, Ferme C, Hennequin C, Frija J, Gisselbrecht C, Boiron M: Cardiopulmonary toxicity after three courses of ABVD and mediastinal irradiation in favourable Hodgkin's disease. Ann Oncol, 2: 73-76, 1991.
4. Cosset JM, Henry-Amar M, Meerwaldt JH: Long-term toxicity of early stages of Hodgkin's disease therapy: the EORTC experience. Ann Oncol 2: 77-82, 1991.
5. Hirsch A, Vander Els N, Straus DJ, Gomez EG, Leung D, Portlock CS, Yahalon J: Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptom in early stage Hodgkin's disease. J Clin Oncol 14: 1297-1305, 1996.
6. GottdienerJS, Katin MJ, Borer JS, Bacharach SL, Green MV: Late cardiac effect of therapeutic mediastinal irradiation. N Eng J Med 308: 569-571, 1983.
7. Gomez GA, Park JJ, Panahon AM, Parthasarathy KL, Pearce J, Reese P, Bakshi S, Henderson ES: Heart size and function after radiation therapy to the mediastinum in patients with Hodgkin's disease. Cancer Treat Rep 67: 1099-1103, 1983.
8. Green DM, Gingell RL, Pearce J, Panahon AM, Ghoorah J: The effect of mediastinal irradiation on cardiac function of patients treated during childhood and adolescence for Hodgkin's disease. J Clin Oncol 5: 239-245, 1987.
9. Dopico GA, Wiley AL, Rao P, Dickie HA: Pulmonary reaction to upper mantle radiation therapy for Hodgkin's disease. Chest 75: 688-692, 1979.
10. Morgan GW, Freeman AP, Mc Lean RG, Jarvie BH, Giles RW: Late cardiac, thyroid and pulmonary sequelae of mantle radiotherapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys 11: 1925-1931, 1985.
11. Watchie J, Coleman CN, Raffin TA, Lox RS, Raubitschek AA, Fahey T, Hoppe RT, Vankessel A: Minimal long term cardiopulmonary dysfunction following treatment for Hodgkin's disease. Int J Radiat Oncol Biol Phys 13: 517-524, 1987.
12. Smith LM, Mendenhall NP, Cicale MJ, Block ER, Carter RL, Million RR: Results of a prospective study evaluating the effects of mantle irradiation on pulmonary function. Int J Radiat Oncol Biol Phys 16: 79-84, 1989.
13. Shapiro SJ, Shapiro SD, Mill WB, Campbell E: Prospective study of long-term pulmonary manifestations of mantle irradiation. Int J Radiat Oncol Biol Phys 19: 707-714, 1990.
14. Chabner BA: Bleomycin. In: Chabner BA (Ed.): Pharmacologic Principles of Cancer Treatment. Philadelphia, PA Saunders, 377-386, 1982.
15. Einhorn L, Krause M, Hornback N, Fumas B: Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell cancer. Cancer 37: 2414-2416, 1976.
16. Boersma LJ, Damen MF, de Boer RW, Muller SH, Valdés Olmos RA, van Zandwijk N, Lebesque JV: Recovery of overall and local lung function loss 18 months after irradiation for malignant lymphoma. J Clin Oncol 14: 1431-1441, 1996.
17. Lagrange JL, Thys A, Caldani C, Héry M, Schneider M, Bersadoun JR: Toxicity of a combination of ABVD chemotherapy and mediastinal irradiation for Hodgkin's disease patients with massive initial mediastinal involvement. Bull Cancer 75: 801-806, 1988.
18. Horning SJ, Adhikari A, Hoppe RT, Olshen RA: Effect of treatment for Hodgkin's disease on pulmonary function: results of a prospective study. J Clin Oncol 12: 297-305, 1994.
19. Olgivie CM, Forster RE, Blakemore WS, Morton JW: A standardized breath-holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest 36: 1-17, 1957.
20. Cotes JE: Measurement of the transfer factor (diffusing capacity) for the lung and its subdivision. In: Lung Function. 4th Edn. Boston, Blackwell Scientific Publications, pp. 230-250, 1979.
21. Dinakara P, Blumenthal WS, Johnston RF, Krufmann LA, Salnik PP: The effect of anaemia on pulmonary diffusing capacity with derivation of a correct equation. Am Rev Respir Dis 102: 965-969, 1970.
22. Lo Kich JJ, Bass M, Eberly FE, Rosenthal DS, Moloney WC: The pulmonary effect of mantle irradiation in patients with Hodgkin's disease. Radiology 108: 397-402, 1973
23. Host M, Yale JR: Lung function after mantle-field irradiation for Hodgkin's disease. Cancer 32: 328-332, 1973.
24. Gross N: Pulmonary effects of radiation therapy. Ann Intern Med 86: 81-92, 1977.
25. Stover DE: Pulmonary toxicity. In: De Vita VT Jr, Hellmann S, Rosenberg SA (Ed.). Cancer: Principles and Practice of Oncology (Ed. 3). Philadelphia, PA, Lippincott pp. 2162-2169, 1989.
26. Ichikawa T: Studies of bleomycin: Discovery of its clinical effect, combination treatment with bleomycin and radiotherapy side effects and long term survival. Jpn J Cancer Res 19: 99-115, 1976.
27. Phillips TL, Wharam MD, Margolis LW: Modification of radiation injury to normal tissue by chemotherapeutic agents. Cancer 35: 1678-1684, 1975.